578 related articles for article (PubMed ID: 31863815)
1. Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.
Sukocheva OA; Furuya H; Ng ML; Friedemann M; Menschikowski M; Tarasov VV; Chubarev VN; Klochkov SG; Neganova ME; Mangoni AA; Aliev G; Bishayee A
Pharmacol Ther; 2020 Mar; 207():107464. PubMed ID: 31863815
[TBL] [Abstract][Full Text] [Related]
2. Sphingolipids as mediators of inflammation and novel therapeutic target in inflammatory bowel disease.
Sukocheva OA; Lukina E; McGowan E; Bishayee A
Adv Protein Chem Struct Biol; 2020; 120():123-158. PubMed ID: 32085881
[TBL] [Abstract][Full Text] [Related]
3. Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming.
Sukocheva OA
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29385066
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic Role of the Sphingosine 1-Phosphate (S1P) Pathway in Common Gynecologic Disorders (GDs): A Possible Novel Therapeutic Target.
Di Paolo A; Vignini A; Alia S; Membrino V; Delli Carpini G; Giannella L; Ciavattini A
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362323
[TBL] [Abstract][Full Text] [Related]
5. A 50-Hz magnetic-field exposure promotes human amniotic cells proliferation via SphK-S1P-S1PR cascade mediated ERK signaling pathway.
Chen L; Xia Y; Lu J; Xie Q; Ye A; Sun W
Ecotoxicol Environ Saf; 2020 May; 194():110407. PubMed ID: 32146198
[TBL] [Abstract][Full Text] [Related]
6. The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy.
Zheng X; Li W; Ren L; Liu J; Pang X; Chen X; Kang D; Wang J; Du G
Pharmacol Ther; 2019 Mar; 195():85-99. PubMed ID: 30347210
[TBL] [Abstract][Full Text] [Related]
7. Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors.
Plano D; Amin S; Sharma AK
J Med Chem; 2014 Jul; 57(13):5509-24. PubMed ID: 24471412
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine kinase 1/sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 pathway: A novel target of geniposide to inhibit angiogenesis.
Sun M; Deng R; Wang Y; Wu H; Zhang Z; Bu Y; Zhang H
Life Sci; 2020 Sep; 256():117988. PubMed ID: 32569777
[TBL] [Abstract][Full Text] [Related]
9. SPHK1/S1P/S1PR pathway promotes the progression of peritoneal fibrosis by mesothelial-mesenchymal transition.
Zhao T; Ding T; Sun Z; Shao X; Li S; Lu H; Yuan JH; Guo Z
FASEB J; 2024 Jan; 38(2):e23417. PubMed ID: 38226856
[TBL] [Abstract][Full Text] [Related]
10. Unravelling the interplay of sphingolipids and TGF-β signaling in the human corneal stroma.
Nicholas SE; Rowsey TG; Priyadarsini S; Mandal NA; Karamichos D
PLoS One; 2017; 12(8):e0182390. PubMed ID: 28806736
[TBL] [Abstract][Full Text] [Related]
11. Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy.
Sukocheva OA; Neganova ME; Aleksandrova Y; Burcher JT; Chugunova E; Fan R; Tse E; Sethi G; Bishayee A; Liu J
Cell Commun Signal; 2024 May; 22(1):251. PubMed ID: 38698424
[TBL] [Abstract][Full Text] [Related]
12. Role of bioactive sphingolipids in physiology and pathology.
Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
[TBL] [Abstract][Full Text] [Related]
13. The role of sphingosine-1-phosphate in the gut mucosal microenvironment and inflammatory bowel diseases.
Zou F; Wang S; Xu M; Wu Z; Deng F
Front Physiol; 2023; 14():1235656. PubMed ID: 37560160
[TBL] [Abstract][Full Text] [Related]
14. Targeting SphK1 as a new strategy against cancer.
Shida D; Takabe K; Kapitonov D; Milstien S; Spiegel S
Curr Drug Targets; 2008 Aug; 9(8):662-73. PubMed ID: 18691013
[TBL] [Abstract][Full Text] [Related]
15. Signaling pathways involved in sphingosine kinase activation and sphingosine-1-phosphate release in rat myometrium in late pregnancy: role in the induction of cyclooxygenase 2.
Serrano-Sanchez M; Tanfin Z; Leiber D
Endocrinology; 2008 Sep; 149(9):4669-79. PubMed ID: 18723875
[TBL] [Abstract][Full Text] [Related]
16. Involvement of released sphingosine 1-phosphate/sphingosine 1-phosphate receptor axis in skeletal muscle atrophy.
Pierucci F; Frati A; Battistini C; Matteini F; Iachini MC; Vestri A; Penna F; Costelli P; Meacci E
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3598-3614. PubMed ID: 30279138
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine kinase 1 as an anticancer therapeutic target.
Gao Y; Gao F; Chen K; Tian ML; Zhao DL
Drug Des Devel Ther; 2015; 9():3239-45. PubMed ID: 26150697
[TBL] [Abstract][Full Text] [Related]
18. Sphk1/S1P/S1PR1 Signaling is Involved in the Development of Autoimmune Thyroiditis in Patients and NOD.H-2
Han C; He X; Xia X; Guo J; Liu A; Liu X; Wang X; Li C; Peng S; Zhao W; Zhou M; Shi X; Li Y; Li Y; Shan Z; Teng W
Thyroid; 2019 May; 29(5):700-713. PubMed ID: 30963819
[No Abstract] [Full Text] [Related]
19. Expression of sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 in malaria-associated acute lung injury/acute respiratory distress syndrome in a mouse model.
Punsawad C; Viriyavejakul P
PLoS One; 2019; 14(9):e0222098. PubMed ID: 31483837
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions.
Fischer I; Alliod C; Martinier N; Newcombe J; Brana C; Pouly S
PLoS One; 2011; 6(8):e23905. PubMed ID: 21887342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
